Navigation Links
Medbox, Inc. Announces Top-Tier Rating by Dun & Bradstreet Credibility Corporation
Date:5/9/2012

HOLLYWOOD, Calif., May 9, 2012 /PRNewswire/ -- Medbox, Inc. (Pinksheets: MDBX) (www.medboxinc.com) announced today that the company, through its wholly owned Subsidiary, Prescription Vending Machines, Inc., has upgraded its credit worthiness and corporate stability ratings to top tier status with Dun & Bradstreet Credibility Corp.  Dun & Bradstreet is a company that is steeped in tradition, woven into the fiber of corporate America in the credit reporting industry, dating back to 1837.

D&B's proprietary set of key ratings include the PAYDEX® Score, a predictive indicator for paying bills on time; the Financial Stress Score, an indicator of financial stress in the next 12 months; and the Credit Limit Recommendation, which provides guidelines for extending business credit and an overall D&B Rating which addresses the overall assessment of a business.

Medbox, Inc. (DUNS: 93-072-9434) ranked in the top two tiers in every one of the criteria listed above as well as in the 87th percentile in commercial credit score as compared to other businesses nationally.

"With the posting of our latest financials and the recent top-tier rating by D&B, we are setting the stage for what is proving to be our most successful year ever," stated Dr. Bruce Bedrick, CEO of Medbox, Inc.

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.

 


'/>"/>
SOURCE Medbox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Medbox, Inc. Announces New Board of Directors After Acquisition of Prescription Vending Machines, Inc.
2. Medbox, Inc. Announces Approval in Colorado House Bill (HB1043)
3. Medbox, Inc. Announces New Product Line for 2012
4. NIAID announces 25 new awards to develop radiation countermeasures
5. Aware Announces Q3 2008 Earnings Conference Call
6. Governor Doyle announces historic genomic research collaboration
7. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
8. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
9. Parkinsons Disease Foundation announces award of $150,000
10. Jefferson Department of Surgery announces new pancreas tumor registry
11. NAS announces initiative to connect entertainment industry with top experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing and ... results for the third quarter and first nine months ... Third Quarter of Fiscal 2017 Highlights ... increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China ... company in China, today announced its financial results for the ... Fourth Quarter 2016 Financial Highlights Total ... in RMB terms, or increased by 13.6% in USD terms ... of 2015. Gross profit increased by 13.3% ...
Breaking Biology Technology: